Effect of Lactoferrin in Obese Children and Adolescents with Metabolic Dysfunction-Associated Steatotic Disease: A Randomized Controlled Study.
- 2026-03-11
- RCT
- Paediatric drugs 28(3)
- Doaa El Amrousy
- Dalia El-Afify
- Esraa Abd Al-Fattah Sorour
- Shymaa Elrifaey
- PubMed: 41811599
- DOI: 10.1007/s40272-026-00742-9
- High evidence
- Clinical
body mass index (28.7 ± 1.48 vs 30.2 ± 1.45, p < 0.001)
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 100 mg once daily for 3 months